Unknown substance withdrawal: Difference between revisions
Jump to navigation
Jump to search
Kiran Singh (talk | contribs) (Created page with "__NOTOC__ {{SI}} {{CMG}} {{AE}} {{KS}} ==Overview== ==References== {{Reflist|1}} Category:DSM-V Diagnostic Criteria Category:Psychiatric Disease Category:Psychiat...") |
Kiran Singh (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Differential Diagnosis== | |||
*Dose reduction after extended dosing, but not meeting the criteria for other (or unknown)substance withdrawal | |||
*Different types of other (or unknown) substance-related disorders | |||
*Other toxic, metabolic, traumatic, neoplastic, vascular, or infectious disorders that impair brain function and cognition | |||
*Substance withdrawal or other substance/medication-induced disorders<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | |||
==Epidemiology and Demographics== | |||
===Prevalence=== | |||
The prevalence of Other (or Unknown) Substance Withdrawal is unknown.<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | |||
==Diagnostic Criteria== | |||
===DSM-V Diagnostic Criteria for Other (or Unknown) Substance Withdrawal <ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>=== | |||
{{cquote| | |||
*A.Cessation of (or reduction in) use of a substance that has been heavy and prolonged. | |||
'''''AND''''' | |||
*B.The development of a substance-specific syndrome shortly after the cessation of (or reduction in) substance use. | |||
'''''AND''''' | |||
*C.The substance-specific syndrome causes clinically significant distress or impairment in social, occupational, or other important areas of functioning. | |||
'''''AND''''' | |||
*D.The symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including withdrawal from another substance. | |||
'''''AND''''' | |||
*E.The substance involved cannot be classified under any of the other substance categories ([[alcohol]]; [[caffeine]]; [[cannabis]]; [[opioids]]; [[Benzodiazepines|sedatives, hypnotics, or anxiolytics]]; stimulants; or tobacco) or is unknown. | |||
}} | |||
==References== | ==References== | ||
{{Reflist|1}} | {{Reflist|1}} | ||
Latest revision as of 22:48, 10 November 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
Overview
Differential Diagnosis
- Dose reduction after extended dosing, but not meeting the criteria for other (or unknown)substance withdrawal
- Different types of other (or unknown) substance-related disorders
- Other toxic, metabolic, traumatic, neoplastic, vascular, or infectious disorders that impair brain function and cognition
- Substance withdrawal or other substance/medication-induced disorders[1]
Epidemiology and Demographics
Prevalence
The prevalence of Other (or Unknown) Substance Withdrawal is unknown.[1]
Diagnostic Criteria
DSM-V Diagnostic Criteria for Other (or Unknown) Substance Withdrawal [1]
| “ |
AND
AND
AND
AND
|
” |
References
- ↑ 1.0 1.1 1.2 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.